BDBM326232 (E)-4-(6-amino-9-(3-(4-(dimethylamino)-N-methylbut-2-enamido)phenyl)-8-oxo-8,9-dihydro-7H-purin-7-yl)-N-(4,5-dimethylthiazol-2-yl)benzamide ::US9637487, Compound 21

SMILES CN(C)C\C=C\C(=O)N(C)c1cccc(c1)-n1c2ncnc(N)c2n(-c2ccc(cc2)C(=O)Nc2nc(C)c(C)s2)c1=O

InChI Key InChIKey=CFZVBDBLVUMDQD-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 326232   

TargetTyrosine-protein kinase BTK(Human)
Pharmacyclics

US Patent
LigandPNGBDBM326232((E)-4-(6-amino-9-(3-(4-(dimethylamino)-N-methylbut...)
Affinity DataIC50: 100nMAssay Description:Human Btk kinase (Genbank accession # NP_000052) was purified from insect cells as a full-length construct containing a N-terminal 6×-His tag. Btk ki...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/29/2019
Entry Details
US Patent